446 related articles for article (PubMed ID: 24107731)
21. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
22. Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism.
Cakir E; Doğan M; Topaloglu O; Ozbek M; Cakal E; Vural MG; Yeter E; Delibasi T
Atherosclerosis; 2013 Jan; 226(1):291-5. PubMed ID: 23206979
[TBL] [Abstract][Full Text] [Related]
23. Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
Kahal H; Aburima A; Ungvari T; Rigby AS; Dawson AJ; Coady AM; Vince RV; Ajjan RA; Kilpatrick ES; Naseem KM; Atkin SL
Clin Endocrinol (Oxf); 2013 Aug; 79(2):252-8. PubMed ID: 23278130
[TBL] [Abstract][Full Text] [Related]
24. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
Zueff LF; Martins WP; Vieira CS; Ferriani RA
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
[TBL] [Abstract][Full Text] [Related]
25. Lipid and lipoprotein profile in women with polycystic ovary syndrome.
Macut D; Panidis D; Glisić B; Spanos N; Petakov M; Bjekić J; Stanojlović O; Rousso D; Kourtis A; Bozić I; Damjanović S
Can J Physiol Pharmacol; 2008 Apr; 86(4):199-204. PubMed ID: 18418429
[TBL] [Abstract][Full Text] [Related]
26. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
27. Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women.
Park JS; Kang S; Ahn CW; Cha BS; Kim KR; Lee HC
Maturitas; 2012 Dec; 73(4):344-8. PubMed ID: 23127592
[TBL] [Abstract][Full Text] [Related]
28. Vascular function in the diagnostic categories of polycystic ovary syndrome.
Moran LJ; Cameron JD; Strauss BJ; Teede HJ
Hum Reprod; 2011 Aug; 26(8):2192-9. PubMed ID: 21616917
[TBL] [Abstract][Full Text] [Related]
29. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
[TBL] [Abstract][Full Text] [Related]
30. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
31. The TyG Index as a Marker of Subclinical Atherosclerosis and Arterial Stiffness in Lean and Overweight Postmenopausal Women.
Lambrinoudaki I; Kazani MV; Armeni E; Georgiopoulos G; Tampakis K; Rizos D; Augoulea A; Kaparos G; Alexandrou A; Stamatelopoulos K
Heart Lung Circ; 2018 Jun; 27(6):716-724. PubMed ID: 28690023
[TBL] [Abstract][Full Text] [Related]
32. Arterial stiffness measured by cardio-ankle vascular index in Korean women with polycystic ovary syndrome.
Kim J; Choi SY; Park B; Park HE; Lee H; Kim MJ; Kim SM; Hwang KR; Choi YM
J Obstet Gynaecol; 2019 Jul; 39(5):681-686. PubMed ID: 30983450
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease risk factors in polycystic ovary syndrome.
Dokras A
Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
[TBL] [Abstract][Full Text] [Related]
34. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
Soares GM; Vieira CS; Martins WP; Franceschini SA; dos Reis RM; Silva de Sá MF; Ferriani RA
Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
Tripathy P; Sahu A; Sahu M; Nagy A
Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
[TBL] [Abstract][Full Text] [Related]
36. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
37. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.
Patel SS; Truong U; King M; Ferland A; Moreau KL; Dorosz J; Hokanson JE; Wang H; Kinney GL; Maahs DM; Eckel RH; Nadeau KJ; Cree-Green M
Vasc Med; 2017 Apr; 22(2):85-95. PubMed ID: 28095749
[TBL] [Abstract][Full Text] [Related]
38. Changes in the PCOS phenotype with age.
Hsu MI
Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
Cussons AJ; Stuckey BG; Watts GF
Atherosclerosis; 2006 Apr; 185(2):227-39. PubMed ID: 16313910
[TBL] [Abstract][Full Text] [Related]
40. Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity--but not a PCOS-associated phenomenon.
Ketel IJ; Stehouwer CD; Henry RM; Serné EH; Hompes P; Homburg R; Smulders YM; Lambalk CB
J Clin Endocrinol Metab; 2010 Oct; 95(10):4566-75. PubMed ID: 20660051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
